Subscribe to RSS



Results Report In Focus: Amgen, Cytokinetics, Biogen Idec, Cosi, Sigma Designs, Geron, Halozyme Therapeutics

Amgen, Inc. (NASDAQ:AMGN) and Cytokinetics, Inc. (NASDAQ:CYTK) extended Amgen’s license for omecamtiv mecarbil in addition to related compounds to include Japan, with Amgen approving to give Cytokinetics $25M as part of an expanded license deal.

Shares of Amgen, Inc. (NASDAQ:AMGN) opened at $98.97 with 749.98 million outstanding shares and touched its highest price of $99.50 during the day and then finished at $96.37 by scoring -1.59%. In the whole session, it traded on volume of 2.57 million shares which turned lower than its average volume.

Cytokinetics, Inc. (NASDAQ:CYTK) stock hit highest price at $1.49, beginning with a price of $1.46 and reported a gain of +10.24% to the closed at $1.40 with a day range of $1.29-$1.49. The total market capitalization remained $205.08 million, total volume of 6.34 million shares held in the session was surprisingly higher than its average volume of 974,799 shares.

Citi cutes its rating for Biogen Idec Inc. (NASDAQ:BIIB) to neutral amid valuation concerns, amid other factors. As its shares plunged -7.39%

Biogen Idec Inc. (NASDAQ:BIIB) begun last trade with a price of $217.70 and throughout the trading session climbed at a high of $218.90. The day-trade ended with a dropped of -7.39% to $206.55. The stock is going forward its 52 week low with 56.47% and lagging behind from its 52 week high price with -14.87%. BIIB last month stock price volatility remained 3.56%.

Fast-casual restaurant chain Cosi Inc (NASDAQ:COSI) released a restructuring plan whereas also naming Executive Chairman Stephen Edwards as its new CEO and president, after the resignation of Carin Stutz.

Cosi Inc (NASDAQ:COSI) stock hit highest price at $2.40, beginning with a price of $2.29 and reported a loss of -11.86% to the closed at $2.08 with a day range of $2.06-$2.40. The total market capitalization remained $38.07 million, total volume of 223,393 shares held in the session was surprisingly higher than its average volume of 120,446 shares.

Sigma Designs Inc (NASDAQ:SIGM) reported on Wednesday that its Q1 net loss of $4.5M or $0.13 a share, lower than $13.7M or $0.42 a share in the similar quarter previous year.

Sigma Designs Inc (NASDAQ:SIGM) stock hit highest price at $5.30, beginning with a price of $5.20 and reported a gain of +1.16% to the closed at $5.24 with a day range of $5.11-$5.30. The stock is going forward its 52 week low with 21.86% and lagging behind from its 52 week high price with -27.22%.

Geron Corporation (NASDAQ:GERN) stock hit highest price at $1.16, beginning with a price of $1.16 and reported a loss of -0.87% to the closed at $1.14 with a day range of $1.13-$1.16. The total market capitalization remained $148.69 million, total volume of 442,298 shares held in the session was surprisingly lower than its average volume of 691,731 shares.

Halozyme Therapeutics, Inc. (NASDAQ:HALO) begun last trade with a price of $6.70 and throughout the trading session climbed at a high of $6.73. The day-trade ended with a decreased of -3.61% to $6.40. The stock is going forward its 52 week low with 25.27% and lagging behind from its 52 week high price with -61.87%. HALO last month stock price volatility remained 4.65%.


Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Entire Disclaimer Here

0 comments

Other articlesgo to homepage

Over-Surged Session Stocks: GW Pharmaceuticals PLC (Nasdaq:GWPH), IntriCon Corp (Nasdaq:IIN), Idera Pharmaceuticals Inc (Nasdaq:IDRA), Intercept Pharmaceuticals Inc (Nasdaq:ICPT), Epizyme Inc (Nasdaq:EPZM)

Over-Surged Session Stocks: GW Pharmaceuticals PLC (Nasdaq:GWPH), IntriCon Corp (Nasdaq:IIN), Idera Pharmaceuticals Inc (Nasdaq:IDRA), Intercept Pharmaceuticals Inc (Nasdaq:ICPT), Epizyme Inc (Nasdaq:EPZM)

Shares of GW Pharmaceuticals plc (Nasdaq:GWPH) are trading on different levels, after research firm Morgan Stanley initiated coverage on the company with an Overweight rating and a price target of $103.00 per share. GWPH stock is currently trading for about $63.61, up $17.57 (or +38.16%), with a volume of 4,988,786 shares traded so far. The

On-top Session Stocks: BioFuel Energy Corp (Nasdaq:BIOF), LiveDeal Inc (Nasdaq:LIVE), Insteel Industries Inc (Nasdaq:IIIN), SGOCO Group Ltd (Nasdaq:SGOC), SanDisk Corp (Nasdaq:SNDK)

On-top Session Stocks: BioFuel Energy Corp (Nasdaq:BIOF), LiveDeal Inc (Nasdaq:LIVE), Insteel Industries Inc (Nasdaq:IIIN), SGOCO Group Ltd (Nasdaq:SGOC), SanDisk Corp (Nasdaq:SNDK)

Shares of BioFuel Energy Corp. (Nasdaq:BIOF) skyrocketed on Thursday’s market activity, currently trading for about $8.20, up $2.14 (or +35.30%), and 5,845,868 of its shares exchanged hands so far BioFuel Energy recently received a preliminary non-binding proposal, which suggested the company acquire acquire all of the equity interests in real-estate developer JBGL Capital and JBGL

Gaining Investiture Session Stocks: Zalicus Inc (Nasdaq:ZLCS), Zogenix Inc (Nasdaq:ZGNX), Lightbridge Corp (Nasdaq:LTBR), Apricus Biosciences Inc (Nasdaq:APRI), Alliqua Inc (Nasdaq:ALQA)

Gaining Investiture Session Stocks: Zalicus Inc (Nasdaq:ZLCS), Zogenix Inc (Nasdaq:ZGNX), Lightbridge Corp (Nasdaq:LTBR), Apricus Biosciences Inc (Nasdaq:APRI), Alliqua Inc (Nasdaq:ALQA)

Shares of Zalicus Inc. (Nasdaq:ZLCS) skyrocketed $0.32 (or +31.07%) to $1.35, following the announcement that Epirus Biopharmaceuticals, Inc., which has closed a $36 million Series B financing round, will merge with a wholly-owned subsidiary of Zalicus, to create a global biosimilar enterprise. 13,616,255 shares of Zalicus were traded on Wednesday, increased activity versus its average

Momentum Overcomers Session Stocks: SmartPros Ltd (Nasdaq:SPRO), Akebia Therapeutics Inc (Nasdaq:AKBA), WebMD Health Corp (Nasdaq:WBMD), bebe stores inc (Nasdaq:BEBE), Chindex International Inc (Nasdaq:CHDX)

Momentum Overcomers Session Stocks: SmartPros Ltd (Nasdaq:SPRO), Akebia Therapeutics Inc (Nasdaq:AKBA), WebMD Health Corp (Nasdaq:WBMD), bebe stores inc (Nasdaq:BEBE), Chindex International Inc (Nasdaq:CHDX)

The trading levels of SmartPros Ltd. (Nasdaq:SPRO) stock exploded on Monday’s market activity, closing at $2.99, up $0.77 (or +34.68%), and 334,315 of its shares exchanged hands during the day, a large increase on activity versus its average volume (3m) of 7,818 On intraday trading, SPRO stock reached a new 52 week high of $3.30

Bullish Prospective Session Stocks: JAKKS Pacific Inc (Nasdaq:JAKK), Rambus Inc (Nasdaq:RMBS), Rentech Inc (Nasdaq:RTK), Oramed Pharmaceuticals Inc (Nasdaq:ORMP), UBIC Inc (Nasdaq:UBIC)

Bullish Prospective Session Stocks: JAKKS Pacific Inc (Nasdaq:JAKK), Rambus Inc (Nasdaq:RMBS), Rentech Inc (Nasdaq:RTK), Oramed Pharmaceuticals Inc (Nasdaq:ORMP), UBIC Inc (Nasdaq:UBIC)

Shares of JAKKS Pacific, Inc. (Nasdaq:JAKK) soared $0.75 (or +9.96%) to $8.28, and 1,043,882 of its shares exchanged hands on Friday’s trading session. JAKKS Pacific, a leading designer and marketer of toys and consumer products, was upgraded from Market Perform to Outperform and its price target raised from $8.00 to $10.00 by brokerage firm BMO

read more

Sign Up*

Receive Our Newsletter!

 



 

 

Contacts and information

Social networks

Most popular categories

© 2014 Crown Equity Holdings Inc. All rights reserved.